About
Technology
Issues
FAQ
Links
Official Page
Safety and efficacy of mitapivat, an oral pyruvate kinase activator, in sickle cell disease: A phase 2, open‐label study
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.